Wealth Management Associates, Inc.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 2067339 Cherry Hill, NJ

Position in BBIO

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$800,957

+$130,018 QoQ

Shares Held

10,754

+19.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#243

of 467 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wealth Management Associates, Inc. holds $2,766,947 across 5 Biotechnology names. BBIO ranks #1 (28.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc. This page	10,754	$800,957
2	ABUS	Arbutus Biopharma Corp	147,995	$710,376
3	IBRX	ImmunityBio, Inc.	69,325	$606,940
4	RVMD	Revolution Medicines, Inc.	2,187	$409,581
5	NAMS	NewAmsterdam Pharma Co N.V.	7,055	$239,093

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$800,957	10,754	+19.0%	Shares	Sole	2026-07-21
2026-03-31	$670,939	9,035	+1.5%	Shares	Sole	2026-05-13
2025-12-31	$680,761	8,900	0.0%	Shares	Sole	2026-01-20
2025-09-30	$462,266	8,900	+4.7%	Shares	Sole	2025-10-21
2025-06-30	$367,030	8,500	-5.3%	Shares	Sole	2025-08-04
2025-03-31	$310,438	8,980	+19.0%	Shares	Sole	2025-05-28
2024-12-31	$207,034	7,545	-22.1%	Shares	Sole	2025-05-28
2024-09-30	$246,452	9,680	-14.9%	Shares	Sole	2025-05-28
2024-06-30	$288,255	11,380	0.0%	Shares	Sole	2025-05-28
2024-03-31	$351,869	11,380	—	Shares	Sole	2025-05-28
No filing history on record for this holder in this stock.